Dane Bowler
Value, hedge fund analyst, REITs, long/short equity
A Prominent Sector Headwind Stifles The Growth Of Sabra Healthcare
Sabra Healthcare (NASDAQ:SBRA) is a strong company, but it has become fully valued through price appreciation and slowing growth. Specifically, SBRA's multiple has increased to approximately 12.7X forward FFO and its formerly rapid growth is threatened by sector headwinds. This article will begin with a review of Sabra's history, examine its future and conclude that it is no longer an opportunistic stock.
A Brief History
Since inception in 2010, SBRA has managed to grow its FFO/share in excess of 70%. Early investors were rewarded with substantially above market returns.
(click to enlarge)
In addition to the price appreciation charted above, SBRA had a large and growing dividend.
(click to enlarge)
Data from SNL Financial
The pertinent aspect of...
Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
| FREE | SA PRO MEMBERS | |
| IDEA GENERATOR | X | Exclusive access to 10 PRO ideas every day |
| INVESTING IDEAS LIBRARY | X | Exclusive access to PRO library of more than 15,000 ideas |
| SECTOR EXPERT NETWORK | X | Exclusive access to all sector experts for direct consultation |
| PERFORMANCE TRACKING | X | Track performance of all PRO stock ideas |
| PROFESSIONAL TOOLS | X | Professional Idea Filters to zero-in based on industry, market cap and more |
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details
